In the process of developing vaccines against influenza, generating influenza virus in cultured cells using a minimal number of plasmid constructs has been a long-term challenge. In an effort to reduce costs and save time in constructing these plasmids a new technology has been developed to generate influenza virus from cultured eukaryotic cells...